Clinical trial

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

NCT02713841

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention inhaled human insulin (INH) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention sc insulin lispro (LIS) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE1 / PHASE2

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

inhaled human insulin (INH)DRUG

sc insulin lispro (LIS)DRUG

Sponsors & collaborators

Dance Biopharm Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02713841 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.